cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2020.1.n693cardio-693Research ArticleОБЗОРЫREVIEWSТрепетание предсердий: современное состояние проблемы с клинических позицийAtrial Flutter: up‐to‐date Problem Evaluation with Clinical Positionshttps://orcid.org/0000-0002-8161-3882ПотаповаК. В.PotapovaK. V.

Потапова Ксения ВасильевнаНижний Новгород

Nizhniy Novgorod

ksenia_medical@mail.ruНосовВ. П.NosovV. P.

Нижний Новгород

Nizhniy Novgorod

КоролеваЛ. Ю.KorolevaL. Y.

Нижний Новгород

Nizhniy Novgorod

АминеваН. В.AminevaN. V.

Нижний Новгород

Nizhniy Novgorod  

natella-amineva@yandex.ruФГБОУ ВО «Приволжский исследовательский медицинский университет» Минздрава РоссииРоссияPrivolzhsky Research Medical UniversityRussian Federation2020040220206017080Copyright © Kardiomag, 20202020KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/693

В обзоре изложены современные представления об этиологии и распространенности трепетания предсердий (ТП), механизме и субстрате аритмогенеза, принципах клинической и электрофизиологической классификации данной аритмии. Подробно описываются методы консервативного и хирургического лечения при ТП, в том числе в сравнительном аспекте. Приводятся последние данные об эффективности и потенциальной опасности тех или иных способов купирования аритмии. Обозначена необходимость ранней диагностики и строгого контроля синусового ритма при ТП как потенциальной возможности повышения успешности интервенционного вмешательства с целью не только полного излечения от имеющейся аритмии, но и профилактики иных нарушений ритма, в первую очередь фибрилляции предсердий.

The review provides current ideas about the etiology and prevalence of atrial flutter (AF), mechanism and substrate of arrhythmogenesis, and principles of clinical and electrophysiological classification of this arrhythmia. Methods for conservative and surgical treatments of AF, including their comparative aspect, are described in detail. The review presented recent data on efficacy and potential risks of different approaches to reversing the arrhythmia. The authors indicated a need for early diagnosis and strict control of the sinus rhythm in AF, which would help a successful intervention not only to completely cure the existing arrhythmia but also to prevent other heart rhythm disorders, primarily atrial fibrillation.

трепетание предсердийэлектрофизиологияклассификацияантикоагулянтная терапияконсервативная терапияхирургическое лечениеAtrial flutterelectrophysiologyclassificationanticoagulant therapyconservative therapysurgical treatmentReferencesCemin R, Manfrin M, Daves M, Rauhe W, Maggioni AP. Ten years differences in recently onset atrial fibrillation and flutter incidence and management. Monaldi Archives for Chest Disease. 2015;82(3):153–9. DOI: 10.4081/monaldi.2014.56Cemin R, Manfrin M, Daves M, Rauhe W, Maggioni AP. Ten years differences in recently onset atrial fibrillation and flutter incidence and management. Monaldi Archives for Chest Disease. 2015;82(3):153–9. DOI: 10.4081/monaldi.2014.56Cardiac electrophysiology: from cell to bedside. Zipes DP, Jalife J, Stevenson WG, editors -Philadelphia, PA: Elsevier;2018. -1389 p. ISBN 978-0-323-44733-1Cardiac electrophysiology: from cell to bedside. Zipes DP, Jalife J, Stevenson WG, editors -Philadelphia, PA: Elsevier;2018. -1389 p. ISBN 978-0-323-44733-1Rahman F, Wang N, Yin X, Ellinor PT, Lubitz SA, LeLorier PA et al. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016;13(1):233–40. DOI: 10.1016/j.hrthm.2015.07.031Rahman F, Wang N, Yin X, Ellinor PT, Lubitz SA, LeLorier PA et al. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016;13(1):233–40. DOI: 10.1016/j.hrthm.2015.07.031Braunwald’s heart disease: a textbook of cardiovascular medicine. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, editors -Philadelphia, PA: Elsevier;2019. -1944 p. ISBN 978-0-323-55592-0Braunwald’s heart disease: a textbook of cardiovascular medicine. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, editors -Philadelphia, PA: Elsevier;2019. -1944 p. ISBN 978-0-323-55592-0Ардашев А.В. Трепетание предсердий: клиническая электрофизиология и катетерная абляция. М.: Медпрактика-М, 2012. 229с. ISBN 978-5-98803-284-7Ardashev A.V. Atrial flutter: clinical electrophysiology and catheter ablation. -M.: Medpraktika-M;2012. -229 p. [Russian] ISBN 978-5-98803-284-7Manolis AS. Contemporary Diagnosis and Management of Atrial Flutter: A Continuum of Atrial Fibrillation and Vice Versa? Cardiology in Review. 2017;25(6):289–97. DOI: 10.1097/CRD.0000000000000162Manolis AS. Contemporary Diagnosis and Management of Atrial Flutter: A Continuum of Atrial Fibrillation and Vice Versa? Cardiology in Review. 2017;25(6):289–97. DOI: 10.1097/CRD.0000000000000162Кушаковский М.С., Гришкин Ю.Н. Аритмии сердца. Расстройства ритма и нарушения проводимости. Причины, механизмы, электрокардиографическая и электрофизиологическая диагностика, клиника, лечение: руководство для врачей. 4-е изд., испр. и доп. -СПб.: Фолиант, 2014. -718с. ISBN 978-5-93929-245-0Kushakovsky M.S., Grishkin Yu.N. Heart arrhythmias. Heart rhythm and conduction disorders. Causes, mechanisms, electrocardiographic and electrophysiological diagnosis, clinic, treatment: A guide for doctors. -4th ed. -St. Petersburg: Foliant;2014. -718 p. [Russian] ISBN 978-5-93929-245-0Josephson ME, Josephson ME. Josephson’s clinical cardiac electrophysiology: techniques and interpretations. -Boston: Wolters Kluwer;2016. -890 p. ISBN 978-1-4511-8741-0Josephson ME, Josephson ME. Josephson’s clinical cardiac electrophysiology: techniques and interpretations. -Boston: Wolters Kluwer;2016. -890 p. ISBN 978-1-4511-8741-0Aguilar M, Nattel S. The pioneering work of George Mines on cardiac arrhythmias: groundbreaking ideas that remain influential in contemporary cardiac electrophysiology. The Journal of Physiology. 2016;594(9):2377–86. DOI: 10.1113/JP270506Aguilar M, Nattel S. The pioneering work of George Mines on cardiac arrhythmias: groundbreaking ideas that remain influential in contemporary cardiac electrophysiology. The Journal of Physiology. 2016;594(9):2377–86. DOI: 10.1113/JP270506Patel NJ, Deshmukh A, Pau D, Goyal V, Patel SV, Patel N et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm. 2016;13(6):1317–25. DOI: 10.1016/j.hrthm.2016.02.005Patel NJ, Deshmukh A, Pau D, Goyal V, Patel SV, Patel N et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm. 2016;13(6):1317–25. DOI: 10.1016/j.hrthm.2016.02.005Левин А.М., Высокович В.К. Основы клинической диагностики: Для врачей и студентов. 2-е изд. Петроград: Изд. тов.»Новое в медицине», 1916. -809сLevin A.M., Vysokovich V.K. The basis for clinical diagnosis: For physicians and students. 2nd ed. -Petrograd: New in medicine;1916. -809 p. [Russian]Ланг Г.Ф. Классификация и номенклатура болезней сердечно-сосудистой системы Терапевтический Архив. 1934;12(1):1-29Lang G.F. Classification and nomenclature of diseases of the cardiovascular system. Therapeutic Archive. 1934;12(1):1–29. [Russian]Olgin JE, Kalman JM, Lesh MD. Conduction Barriers in Human Atrial Flutter: Correlation of Electrophysiology and Anatomy. Journal of Cardiovascular Electrophysiology. 1996;7(11):1112–26. DOI: 10.1111/j.1540-8167.1996.tb00488.xOlgin JE, Kalman JM, Lesh MD. Conduction Barriers in Human Atrial Flutter: Correlation of Electrophysiology and Anatomy. Journal of Cardiovascular Electrophysiology. 1996;7(11):1112–26. DOI: 10.1111/j.1540-8167.1996.tb00488.xTai C-T, Huang J-L, Lee P-C, Ding Y-A, Chang M-S, Chen S-A. High-Resolution Mapping Around the Crista Terminalis During Typical Atrial Flutter:. New Insights into Mechanisms. Journal of Cardiovascular Electrophysiology. 2004;15(4):406–14. DOI: 10.1046/j.1540-8167.2004.03535.xTai C-T, Huang J-L, Lee P-C, Ding Y-A, Chang M-S, Chen S-A. High-Resolution Mapping Around the Crista Terminalis During Typical Atrial Flutter:. New Insights into Mechanisms. Journal of Cardiovascular Electrophysiology. 2004;15(4):406–14. DOI: 10.1046/j.1540-8167.2004.03535.xFeld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation. 1992;86(4):1233–40. DOI: 10.1161/01.CIR.86.4.1233Tai C-T, Huang J-L, Lee P-C, Ding Y-A, Chang M-S, Chen S-A. High-Resolution Mapping Around the Crista Terminalis During Typical Atrial Flutter:. New Insights into Mechanisms. Journal of Cardiovascular Electrophysiology. 2004;15(4):406–14. DOI: 10.1046/j.1540-8167.2004.03535.xCosio FG, López-Gil M, Goicolea A, Arribas F, Barroso JoséL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. The American Journal of Cardiology. 1993;71(8):705–9. DOI: 10.1016/0002-9149(93)91014-9Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation. 1992;86(4):1233–40. DOI: 10.1161/01.CIR.86.4.1233Lesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994;89(3):1074–89. DOI: 10.1161/01.CIR.89.3.1074Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation. 1992;86(4):1233–40. DOI: 10.1161/01.CIR.86.4.1233ai C-T, Chen S-A, Chiang C-E, Lee S-H, Ueng K-C, Wen Z-C et al. Electrophysiologic Characteristics and Radiofrequency Catheter Ablation in Patients with Clockwise Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(1):24–34. DOI: 10.1111/j.1540-8167.1997.tb00605.xCosio FG, López-Gil M, Goicolea A, Arribas F, Barroso JoséL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. The American Journal of Cardiology. 1993;71(8):705–9. DOI: 10.1016/0002-9149(93)91014-9Cosio FG, Goicolea A, López-Gil M, Arribas F, Barroso J, Chicote R. Atrial endocardial mapping in the rare form of atrial flutter. The American Journal of Cardiology. 1990;66(7):715–20. DOI: 10.1016/0002-9149(90)91136-TCosio FG, López-Gil M, Goicolea A, Arribas F, Barroso JoséL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. The American Journal of Cardiology. 1993;71(8):705–9. DOI: 10.1016/0002-9149(93)91014-9Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in atrial flutter. Journal of the American College of Cardiology. 1990;16(7):1639–48. DOI: 10.1016/0735-1097(90)90314-FLesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994;89(3):1074–89. DOI: 10.1161/01.CIR.89.3.1074Feld GK, Mollerus M, Birgersdotter-Green U, Fujimura O, Bahnson TD, Boyce K et al. Conduction Velocity in the Tricuspid ValveInferior Vena Cava Isthmus is Slower in Patients With Type I Atrial Flutter Compared to Those Without a History of Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(12):1338–48. DOI: 10.1111/j.1540-8167.1997.tb01030.xLesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ et al. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994;89(3):1074–89. DOI: 10.1161/01.CIR.89.3.1074Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle. A model of reentry based on anisotropic discontinuous propagation. Circulation Research. 1988;62(4):811–32. DOI: 10.1161/01.RES.62.4.811ai C-T, Chen S-A, Chiang C-E, Lee S-H, Ueng K-C, Wen Z-C et al. Electrophysiologic Characteristics and Radiofrequency Catheter Ablation in Patients with Clockwise Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(1):24–34. DOI: 10.1111/j.1540-8167.1997.tb00605.xCabrera JA, Sánchez-Quintana D, Farré J, Rubio JM, Ho SY. The Inferior Right Atrial Isthmus: Further Architectural Insights for Current and Coming Ablation Technologies. Journal of Cardiovascular Electrophysiology. 2005;16(4):402–8. DOI: 10.1046/j.1540-8167.2005.40709.xai C-T, Chen S-A, Chiang C-E, Lee S-H, Ueng K-C, Wen Z-C et al. Electrophysiologic Characteristics and Radiofrequency Catheter Ablation in Patients with Clockwise Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(1):24–34. DOI: 10.1111/j.1540-8167.1997.tb00605.xЧаплыгина Е.В., Чудинов Г.В., Корниенко Н.А. Особенности строения правого предсердия при электроанатомическом картировании. Журнал фундаментальной медицины и биологии. 2012;2:50-4Cosio FG, Goicolea A, López-Gil M, Arribas F, Barroso J, Chicote R. Atrial endocardial mapping in the rare form of atrial flutter. The American Journal of Cardiology. 1990;66(7):715–20. DOI: 10.1016/0002-9149(90)91136-TSaoudi N, Cosio F, Waldo A, Chen SA, Iesaka Y, Lesh M et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. A Statement from a Joint Expert Group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. European Heart Journal. 2001;22(14):1162–82. DOI: 10.1053/euhj.2001.2658Cosio FG, Goicolea A, López-Gil M, Arribas F, Barroso J, Chicote R. Atrial endocardial mapping in the rare form of atrial flutter. The American Journal of Cardiology. 1990;66(7):715–20. DOI: 10.1016/0002-9149(90)91136-THuang SK, Miller JM. Catheter ablation of cardiac arrhythmias. 4th ed. Elsevier;2019. 834 p. ISBN 978-0-323-52992-1Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in atrial flutter. Journal of the American College of Cardiology. 1990;16(7):1639–48. DOI: 10.1016/0735-1097(90)90314-FHuang JL, Tai C-T, Lin Y-J, Huang B-H, Lee K-T, Higa S et al. Substrate Mapping to Detect Abnormal Atrial Endocardium With Slow Conduction in Patients With Atypical Right Atrial Flutter. Journal of the American College of Cardiology. 2006;48(3):492–8. DOI: 10.1016/j.jacc.2006.03.045Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in atrial flutter. Journal of the American College of Cardiology. 1990;16(7):1639–48. DOI: 10.1016/0735-1097(90)90314-FGiehm-Reese M, Lukac P, Kristiansen SB, Jensen HK, Gerdes C, Kristensen J et al. Outcome after catheter ablation for left atrial flutter. Scandinavian Cardiovascular Journal. 2019;53(3):133–40. DOI: 10.1080/14017431.2019.1612086Feld GK, Mollerus M, Birgersdotter-Green U, Fujimura O, Bahnson TD, Boyce K et al. Conduction Velocity in the Tricuspid ValveInferior Vena Cava Isthmus is Slower in Patients With Type I Atrial Flutter Compared to Those Without a History of Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(12):1338–48. DOI: 10.1111/j.1540-8167.1997.tb01030.xZhou G, Hu J, Guo X, Liu X, Yang J, Sun Q et al. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. International Journal of Cardiology. 2016;205:72–80. DOI: 10.1016/j.ijcard.2015.12.004Feld GK, Mollerus M, Birgersdotter-Green U, Fujimura O, Bahnson TD, Boyce K et al. Conduction Velocity in the Tricuspid ValveInferior Vena Cava Isthmus is Slower in Patients With Type I Atrial Flutter Compared to Those Without a History of Atrial Flutter. Journal of Cardiovascular Electrophysiology. 1997;8(12):1338–48. DOI: 10.1111/j.1540-8167.1997.tb01030.xPérez FJ, Wood MA, Schubert CM. Effects of Gap Geometry on Conduction Through Discontinuous Radiofrequency Lesions. Circulation. 2006;113(14):1723–9. DOI: 10.1161/CIRCULATIONAHA.105.596593Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle. A model of reentry based on anisotropic discontinuous propagation. Circulation Research. 1988;62(4):811–32. DOI: 10.1161/01.RES.62.4.811January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16(8):e66–93. DOI: 10.1016/j.hrthm.2019.01.024Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle. A model of reentry based on anisotropic discontinuous propagation. Circulation Research. 1988;62(4):811–32. DOI: 10.1161/01.RES.62.4.811Vadmann H, Nielsen PB, Hjortshøj SP, Riahi S, Rasmussen LH, Lip GYH et al. Atrial flutter and thromboembolic risk: a systematic review. Heart. 2015;101(18):1446–55. DOI: 10.1136/heartjnl-2015-307550Cabrera JA, Sánchez-Quintana D, Farré J, Rubio JM, Ho SY. The Inferior Right Atrial Isthmus: Further Architectural Insights for Current and Coming Ablation Technologies. Journal of Cardiovascular Electrophysiology. 2005;16(4):402–8. DOI: 10.1046/j.1540-8167.2005.40709.xGula LJ, Redfearn DP, Jenkyn KB, Allen B, Skanes AC, Leong-Sit P et al. Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter—A Population-Based Study. Canadian Journal of Cardiology. 2018;34(6):774–83. DOI: 10.1016/j.cjca.2018.01.001Cabrera JA, Sánchez-Quintana D, Farré J, Rubio JM, Ho SY. The Inferior Right Atrial Isthmus: Further Architectural Insights for Current and Coming Ablation Technologies. Journal of Cardiovascular Electrophysiology. 2005;16(4):402–8. DOI: 10.1046/j.1540-8167.2005.40709.xAl-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases. 2018;27(4):839–44. DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.025Chaplygina E.V., Chudinov G.V., Kornienko N.A. Structural peculiarities in electroanatomi right atrium mapping. Journal of Fundamental Medicine and Biology. 2012;2:50–4. [Russian]Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B et al. Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation. Journal of the American College of Cardiology. 2014;63(11):1082–7. DOI: 10.1016/j.jacc.2013.09.062Chaplygina E.V., Chudinov G.V., Kornienko N.A. Structural peculiarities in electroanatomi right atrium mapping. Journal of Fundamental Medicine and Biology. 2012;2:50–4. [Russian]Monteiro JMC, San-Martin DL, Silva BCG, Souza IFB, Oliveira Filho J, Jesus P. Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de NeuroPsiquiatria. 2019;77(2):80–3. DOI: 10.1590/0004-282x20190005Saoudi N, Cosio F, Waldo A, Chen SA, Iesaka Y, Lesh M et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. A Statement from a Joint Expert Group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. European Heart Journal. 2001;22(14):1162–82. DOI: 10.1053/euhj.2001.2658Lehrmann H, Weber R, Park C, Allgeier J, Schiebeling-Römer J, Arentz T et al. “Dormant transisthmus conduction” revealed by adenosine after cavotricuspid isthmus ablation. Heart Rhythm. 2012;9(12):1942–6. DOI: 10.1016/j.hrthm.2012.08.020Saoudi N, Cosio F, Waldo A, Chen SA, Iesaka Y, Lesh M et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. A Statement from a Joint Expert Group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. European Heart Journal. 2001;22(14):1162–82. DOI: 10.1053/euhj.2001.2658Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). European Heart Journal. 2019;ehz467. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehz467Huang SK, Miller JM. Catheter ablation of cardiac arrhythmias. 4th ed. Elsevier;2019. 834 p. ISBN 978-0-323-52992-1Jin M-N, Song C, Kim T-H, Uhm J-S, Pak H-N, Lee M-H et al. CHA2DS2-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter. Yonsei Medical Journal. 2018;59(2):236–42. DOI: 10.3349/ymj.2018.59.2.236Huang SK, Miller JM. Catheter ablation of cardiac arrhythmias. 4th ed. Elsevier;2019. 834 p. ISBN 978-0-323-52992-1Scheuermeyer FX, Pourvali R, Rowe BH, Grafstein E, Heslop C, MacPhee J et al. Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm. Annals of Emergency Medicine. 2015;65(5):511-522.e2. DOI: 10.1016/j.annemergmed.2014.09.012Huang JL, Tai C-T, Lin Y-J, Huang B-H, Lee K-T, Higa S et al. Substrate Mapping to Detect Abnormal Atrial Endocardium With Slow Conduction in Patients With Atypical Right Atrial Flutter. Journal of the American College of Cardiology. 2006;48(3):492–8. DOI: 10.1016/j.jacc.2006.03.045Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J et al. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department. The Journal of Emergency Medicine. 2015;49(2):175–82. DOI: 10.1016/j.jemermed.2015.01.014Huang JL, Tai C-T, Lin Y-J, Huang B-H, Lee K-T, Higa S et al. Substrate Mapping to Detect Abnormal Atrial Endocardium With Slow Conduction in Patients With Atypical Right Atrial Flutter. Journal of the American College of Cardiology. 2006;48(3):492–8. DOI: 10.1016/j.jacc.2006.03.045Ревишвили А.Ш., Шляхто Е.В., Попов С.В., Покушалов Е.А., Школьникова М.А., Сулимов В.А. и др. Клинические рекомендации по проведению электрофизиологических исследований, катетерной аблации и применению имплантируемых антиаритмических устройств. -M.:ВНОА, 2017. -702с. ISBN: 978-5-9500922-0-6 (Доступно на: http://webmed.irkutsk.ru/doc/pdf/vnoa.pdf)Giehm-Reese M, Lukac P, Kristiansen SB, Jensen HK, Gerdes C, Kristensen J et al. Outcome after catheter ablation for left atrial flutter. Scandinavian Cardiovascular Journal. 2019;53(3):133–40. DOI: 10.1080/14017431.2019.1612086Shah SR, Luu S-W, Calestino M, David J, Christopher B. Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence. Journal of Community Hospital Internal Medicine Perspectives. 2018;8(5):269–75. DOI: 10.1080/20009666.2018.1514932Giehm-Reese M, Lukac P, Kristiansen SB, Jensen HK, Gerdes C, Kristensen J et al. Outcome after catheter ablation for left atrial flutter. Scandinavian Cardiovascular Journal. 2019;53(3):133–40. DOI: 10.1080/14017431.2019.1612086Frommeyer G, Brachmann J, Ince H, Spitzer SG, Thomas D, Willems S et al. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry. Clinical Research in Cardiology. 2019;108(10):1083–92. DOI: 10.1007/s00392-019-01442-wZhou G, Hu J, Guo X, Liu X, Yang J, Sun Q et al. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. International Journal of Cardiology. 2016;205:72–80. DOI: 10.1016/j.ijcard.2015.12.004Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):471–505. DOI: 10.1161/CIR.0000000000000310Zhou G, Hu J, Guo X, Liu X, Yang J, Sun Q et al. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. International Journal of Cardiology. 2016;205:72–80. DOI: 10.1016/j.ijcard.2015.12.004Sestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. European Review for Medical and Pharmacological Sciences. 2012;16(2):242–53. PMID: 22428477Pérez FJ, Wood MA, Schubert CM. Effects of Gap Geometry on Conduction Through Discontinuous Radiofrequency Lesions. Circulation. 2006;113(14):1723–9. DOI: 10.1161/CIRCULATIONAHA.105.596593Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481Pérez FJ, Wood MA, Schubert CM. Effects of Gap Geometry on Conduction Through Discontinuous Radiofrequency Lesions. Circulation. 2006;113(14):1723–9. DOI: 10.1161/CIRCULATIONAHA.105.596593Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16(8):e66–93. DOI: 10.1016/j.hrthm.2019.01.024Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16(8):e66–93. DOI: 10.1016/j.hrthm.2019.01.024Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198Vadmann H, Nielsen PB, Hjortshøj SP, Riahi S, Rasmussen LH, Lip GYH et al. Atrial flutter and thromboembolic risk: a systematic review. Heart. 2015;101(18):1446–55. DOI: 10.1136/heartjnl-2015-307550Майков Е.Б., Юричева Ю.А., Миронов Н.Ю., Соколов С.Ф., Голицын С.П., Розенштраух Л.В. и др. Рефралон (ниферидил) — новый антиаритмический препарат III класса для медикаментозной кардиоверсии персистирующей фибрилляции и трепетания предсердий. Терапевтический Архив. 2015;87(1):38-48. DOI: 10.17116/terarkh201587138-48Vadmann H, Nielsen PB, Hjortshøj SP, Riahi S, Rasmussen LH, Lip GYH et al. Atrial flutter and thromboembolic risk: a systematic review. Heart. 2015;101(18):1446–55. DOI: 10.1136/heartjnl-2015-307550Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580Gula LJ, Redfearn DP, Jenkyn KB, Allen B, Skanes AC, Leong-Sit P et al. Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter—A Population-Based Study. Canadian Journal of Cardiology. 2018;34(6):774–83. DOI: 10.1016/j.cjca.2018.01.001Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247Gula LJ, Redfearn DP, Jenkyn KB, Allen B, Skanes AC, Leong-Sit P et al. Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter—A Population-Based Study. Canadian Journal of Cardiology. 2018;34(6):774–83. DOI: 10.1016/j.cjca.2018.01.001Соколов С.Ф., Бомонина Е.В. Сравнительная эффективность и безопасность аллапинина, этацизина и амиодарона и выбор оптимальной антиаритмической терапии по контролю ритма при пароксизмальной мерцательной аритмии. Кардиология: новости, мнения, обучение. 2015;3(6):65-75Al-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases. 2018;27(4):839–44. DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.025Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407Al-Kawaz M, Omran SS, Parikh NS, Elkind MSV, Soliman EZ, Kamel H. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation. Journal of Stroke and Cerebrovascular Diseases. 2018;27(4):839–44. DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.025Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B et al. Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation. Journal of the American College of Cardiology. 2014;63(11):1082–7. DOI: 10.1016/j.jacc.2013.09.062Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B et al. Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation. Journal of the American College of Cardiology. 2014;63(11):1082–7. DOI: 10.1016/j.jacc.2013.09.062Олесин А.И., Смолин З.Ю., Коновалова О.А., Шабров А.В. Оценка эффективности чреспищеводной электрокардиостимуляции для купирования впервые выявленного трепетания предсердий I типа у больных ишемической болезнью сердца. Терапевтический Архив. 2009;81(9):37-41Monteiro JMC, San-Martin DL, Silva BCG, Souza IFB, Oliveira Filho J, Jesus P. Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de NeuroPsiquiatria. 2019;77(2):80–3. DOI: 10.1590/0004-282x20190005Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040Monteiro JMC, San-Martin DL, Silva BCG, Souza IFB, Oliveira Filho J, Jesus P. Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de NeuroPsiquiatria. 2019;77(2):80–3. DOI: 10.1590/0004-282x20190005Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672Lehrmann H, Weber R, Park C, Allgeier J, Schiebeling-Römer J, Arentz T et al. “Dormant transisthmus conduction” revealed by adenosine after cavotricuspid isthmus ablation. Heart Rhythm. 2012;9(12):1942–6. DOI: 10.1016/j.hrthm.2012.08.020Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251Lehrmann H, Weber R, Park C, Allgeier J, Schiebeling-Römer J, Arentz T et al. “Dormant transisthmus conduction” revealed by adenosine after cavotricuspid isthmus ablation. Heart Rhythm. 2012;9(12):1942–6. DOI: 10.1016/j.hrthm.2012.08.020Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). European Heart Journal. 2019;ehz467. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehz467Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). European Heart Journal. 2019;ehz467. [Epub ahead of print]. DOI: 10.1093/eurheartj/ehz467Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137Jin M-N, Song C, Kim T-H, Uhm J-S, Pak H-N, Lee M-H et al. CHA2DS2-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter. Yonsei Medical Journal. 2018;59(2):236–42. DOI: 10.3349/ymj.2018.59.2.236Yang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.xJin M-N, Song C, Kim T-H, Uhm J-S, Pak H-N, Lee M-H et al. CHA2DS2-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter. Yonsei Medical Journal. 2018;59(2):236–42. DOI: 10.3349/ymj.2018.59.2.236Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312Scheuermeyer FX, Pourvali R, Rowe BH, Grafstein E, Heslop C, MacPhee J et al. Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm. Annals of Emergency Medicine. 2015;65(5):511-522.e2. DOI: 10.1016/j.annemergmed.2014.09.012Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258Scheuermeyer FX, Pourvali R, Rowe BH, Grafstein E, Heslop C, MacPhee J et al. Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm. Annals of Emergency Medicine. 2015;65(5):511-522.e2. DOI: 10.1016/j.annemergmed.2014.09.012Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J et al. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department. The Journal of Emergency Medicine. 2015;49(2):175–82. DOI: 10.1016/j.jemermed.2015.01.014Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J et al. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department. The Journal of Emergency Medicine. 2015;49(2):175–82. DOI: 10.1016/j.jemermed.2015.01.014Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452Revishvili A.Sh., Shlyakhto E.V., Popov S.V., Pokushalov E.A., Shkolnikova M.A., Sulimov V.A. et al. Clinical recommendations for electrophysiological studies, catheter ablation and implantable antiarrhythmic devices. -M.: VNOA;2017. -702 p. [Russian] ISBN: 978-5-9500922-0-6 (http://webmed.irkutsk.ru/doc/pdf/vnoa.pdf)Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918Revishvili A.Sh., Shlyakhto E.V., Popov S.V., Pokushalov E.A., Shkolnikova M.A., Sulimov V.A. et al. Clinical recommendations for electrophysiological studies, catheter ablation and implantable antiarrhythmic devices. -M.: VNOA;2017. -702 p. [Russian] ISBN: 978-5-9500922-0-6 (http://webmed.irkutsk.ru/doc/pdf/vnoa.pdf)De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570Shah SR, Luu S-W, Calestino M, David J, Christopher B. Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence. Journal of Community Hospital Internal Medicine Perspectives. 2018;8(5):269–75. DOI: 10.1080/20009666.2018.1514932Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008Shah SR, Luu S-W, Calestino M, David J, Christopher B. Management of atrial fibrillation-flutter: uptodate guideline paper on the current evidence. Journal of Community Hospital Internal Medicine Perspectives. 2018;8(5):269–75. DOI: 10.1080/20009666.2018.1514932Teh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.xFrommeyer G, Brachmann J, Ince H, Spitzer SG, Thomas D, Willems S et al. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry. Clinical Research in Cardiology. 2019;108(10):1083–92. DOI: 10.1007/s00392-019-01442-wExpósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538Frommeyer G, Brachmann J, Ince H, Spitzer SG, Thomas D, Willems S et al. Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation Registry. Clinical Research in Cardiology. 2019;108(10):1083–92. DOI: 10.1007/s00392-019-01442-wSteinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):471–505. DOI: 10.1161/CIR.0000000000000310Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133(14):471–505. DOI: 10.1161/CIR.0000000000000310Medi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.xSestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. European Review for Medical and Pharmacological Sciences. 2012;16(2):242–53. PMID: 22428477Sestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. European Review for Medical and Pharmacological Sciences. 2012;16(2):242–53. PMID: 22428477Sestito A, Molina E. Atrial fibrillation and the pharmacological treatment: the role of propafenone. European Review for Medical and Pharmacological Sciences. 2012;16(2):242–53. PMID: 22428477Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481Vinson DR, Lugovskaya N, Warton EM, Rome AM, Stevenson MD, Reed ME et al. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department. Annals of Emergency Medicine. 2018;71(1):96-108.e2. DOI: 10.1016/j.annemergmed.2017.07.481Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal of Cardiovascular Pharmacology and Therapeutics. 2019;24(1):3–10. DOI: 10.1177/1074248418784288Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M et al. Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter. Circulation: Arrhythmia and Electrophysiology. 2015;8(4):772–6. DOI: 10.1161/CIRCEP.114.002339Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198Hamilton A, Clark D, Gray A, Cragg A, Grubb N. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. European Journal of Emergency Medicine. 2015;22(3):155–61. DOI: 10.1097/MEJ.0000000000000198Maykov E.B., Yuricheva Yu.A., Mironov N.Yu., Sokolov S.F., Golitsyn S.P., Rozenshtraukh L.V. et al. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. Therapeutic Archive. 2015;87(1):38–48. [Russian] DOI: 10.17116/terarkh201587138-48Maykov E.B., Yuricheva Yu.A., Mironov N.Yu., Sokolov S.F., Golitsyn S.P., Rozenshtraukh L.V. et al. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. Therapeutic Archive. 2015;87(1):38–48. [Russian] DOI: 10.17116/terarkh201587138-48Maykov E.B., Yuricheva Yu.A., Mironov N.Yu., Sokolov S.F., Golitsyn S.P., Rozenshtraukh L.V. et al. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. Therapeutic Archive. 2015;87(1):38–48. [Russian] DOI: 10.17116/terarkh201587138-48Maykov E.B., Yuricheva Yu.A., Mironov N.Yu., Sokolov S.F., Golitsyn S.P., Rozenshtraukh L.V. et al. Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter. Therapeutic Archive. 2015;87(1):38–48. [Russian] DOI: 10.17116/terarkh201587138-48Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247Naccarelli G, Kowey P. The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS. Current Cardiology Reviews. 2014;10(4):303–8. DOI: 10.2174/1573403X10666140513110247Sokolov S.F., Bomonina E.V. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015;3(6):65–75. [Russian]Sokolov S.F., Bomonina E.V. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015;3(6):65–75. [Russian]Sokolov S.F., Bomonina E.V. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015;3(6):65–75. [Russian]Sokolov S.F., Bomonina E.V. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015;3(6):65–75. [Russian]Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407Kirkland S, Stiell I, AlShawabkeh T, Campbell S, Dickinson G, Rowe BH. The Efficacy of Pad Placement for Electrical Cardioversion of Atrial Fibrillation/Flutter: A Systematic Review. Academic Emergency Medicine. 2014;21(7):717–26. DOI: 10.1111/acem.12407Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JEK et al. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. EP Europace. 2013;15(10):1432–5. DOI: 10.1093/europace/eut106Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9Сулимов В. А., Дубровский И. А., Канорский С. Г. и др. Чреспищеводная электрическая стимуляция сердца, 2-е издание. – М.:ГЭОТАР-Медиа, 2015. 216с. ISBN 978-5-9704-3209-9Olesin A.I., Smolin Z.Yu., Konovalova O.A., Shabrov A.V. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. Therapeutic Archive. 2009;81(9):37– 41. [Russian]Olesin A.I., Smolin Z.Yu., Konovalova O.A., Shabrov A.V. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. Therapeutic Archive. 2009;81(9):37– 41. [Russian]Olesin A.I., Smolin Z.Yu., Konovalova O.A., Shabrov A.V. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. Therapeutic Archive. 2009;81(9):37– 41. [Russian]Olesin A.I., Smolin Z.Yu., Konovalova O.A., Shabrov A.V. Evaluation of the effectiveness of transesophageal electrocardiostimulation for the treatment of the first detected atrial flutter type I in patients with coronary heart disease. Therapeutic Archive. 2009;81(9):37– 41. [Russian]Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A et al. Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia. The American Journal of Cardiology. 2009;104(5):671– 7. DOI: 10.1016/j.amjcard.2009.04.040Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672Brembilla-Perrot B, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D et al. Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients. PLOS ONE. 2015;10(5):e0127672. DOI: 10.1371/journal.pone.0127672Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251Zeng Q, Li X, Xu G. Evaluation of myocardial injury induced by different ablation approaches (radiofrequency ablation versus cryoablation) in atrial flutter patients: a meta-analysis. Bioscience Reports. 2019;39(5):BSR20182251. DOI: 10.1042/BSR20182251Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-Term Outcomes After Catheter Ablation of CavoTricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):393–401. DOI: 10.1161/CIRCEP.109.871665Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707Kumar S, Morton JB, Lee G, Halloran K, Kistler PM, Kalman JM. High Incidence of Low Catheter-Tissue Contact Force at the Cavotricuspid Isthmus During Catheter Ablation of Atrial Flutter: Implications for Achieving Isthmus Block. Journal of Cardiovascular Electrophysiology. 2015;26(8):826–31. DOI: 10.1111/jce.12707Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137Venier S, Andrade JG, Khairy P, Mondésert B, Dyrda K, Rivard L et al. Contact-force-guided vs. contact-force-blinded catheter ablation of typical atrial flutter: a prospective study. Europace. 2016;19(6):1043–8. DOI: 10.1093/europace/euw137Yang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.xYang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.xYang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.xYang Y, Varma N, Badhwar N, Tanel RE, Sundara S, Lee RJ et al. Prospective Observations in the Clinical and Electrophysiological Characteristics of Intra-Isthmus Reentry. Journal of Cardiovascular Electrophysiology. 2010;21(10):1099–106. DOI: 10.1111/j.1540-8167.2010.01778.xCoffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS et al. Catheter ablation of scar-related atypical atrial flutter. EP Europace. 2013;15(3):414–9. DOI: 10.1093/europace/eus312Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258Skjøth F, Vadmann H, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International Journal of Clinical Practice. 2018;72(11):e13258. DOI: 10.1111/ijcp.13258Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406Lin Y, Chen T, Chi C, Lin M, Tung T, Liu C et al. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study. Journal of the American Heart Association. 2017;6(7):e006406. DOI: 10.1161/JAHA.117.006406Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069Bogossian H, Frommeyer G, Brachmann J, Lewalter T, Hoffmann E, Kuck KH et al. Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry. International Journal of Cardiology. 2016;214:25–30. DOI: 10.1016/j.ijcard.2016.03.069Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020–9. DOI: 10.1093/eurheartj/ehy452Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918Warchoł I, Bińkowski BJ, Kucejko T, Sobiczewska J, Lubiński A. A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter. Medical Science Monitor. 2019;25:3316–20. DOI: 10.12659/MSM.912918De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570De Bortoli A, Shi L-B, Ohm O-J, Hoff PI, Schuster P, Solheim E et al. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 2017;51(3):123–8. DOI: 10.1080/14017431.2017.1304570Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008Chen K, Bai R, Deng W, Gao C, Zhang J, Wang X et al. HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter. Heart Rhythm. 2015;12(7):1483–9. DOI: 10.1016/j.hrthm.2015.04.008Teh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.xTeh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.xTeh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.xTeh AW, Medi C, Lee G, Rosso R, Sparks PB, Morton JB et al. Longterm Outcome Following Ablation of Atrial Flutter Occurring Late after Atrial Septal Defect Repair: LATE AF AFTER ASD REPAIR SURGERY. Pacing and Clinical Electrophysiology. 2011;34(4):431–5. DOI: 10.1111/j.1540-8159.2010.03005.xExpósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538Expósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538Expósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538Expósito V, Rodríguez-Entem F, González-Enríquez S, Veiga G, Olavarri I, Olalla JJ. Stroke and Systemic Embolism After Successful Ablation of Typical Atrial Flutter. Clinical Cardiology. 2016;39(6):347–51. DOI: 10.1002/clc.22538Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011Steinberg JS, Romanov A, Musat D, Preminger M, Bayramova S, Artyomenko S et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: The PReVENT AF Study I. Heart Rhythm. 2014;11(9):1567–72. DOI: 10.1016/j.hrthm.2014.05.011Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069Stiles MK, Wong CX, John B, Kuklik P, Brooks AG, Lau DH et al. Characterization of Atrial Remodeling Studied Remote from Episodes of Typical Atrial Flutter. The American Journal of Cardiology. 2010;106(4):528–34. DOI: 10.1016/j.amjcard.2010.03.069Medi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.xMedi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.xMedi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.xMedi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2012;23(10):1067–72. DOI: 10.1111/j.1540-8167.2012.02364.x

The authors declare that there are no conflicts of interest present.